NEW YORK (Associated Press) - More than 800 pharmaceutical jobs will be leaving New Jersey starting in August. Most of the job cuts and transfers are part of major previously announced restructurings at Johnson & Johnson and Schering-Plough Corp. This week, the companies specified how many of those jobs would be lost at New Jersey locations. Schering-Plough, based in Kenilworth, is cutting 500 jobs. New Brunswick-based J&J is eliminating 22 jobs at its Ortho Biotech unit in Bridgewater, shifting another 260 to its Centocor unit in Horsham, Pa., and cutting another 267 Ortho Biotect jobs outside New Jersey. Centocor and Ortho Biotech are consolidating their operations. Both J&J and Schering-Plough face slumping sales for key drugs. Meanwhile, Abbott Laboratories in Parsippany is cutting 83 jobs.
